Dow Jones 30 Stocks SEC Filings — August 04, 2026
The 19 filings from Dow 30 constituents reveal a bifurcated earnings season: industrial and resource-linked names like Caterpillar and Honeywell show robust growth and strong capital returns, while consumer-facing giants McDonald's, Procter & Gamble, and Walmart signal slowing demand and margin pressure. Healthcare leaders Merck and Amgen face growth challenges in legacy products but are investing heavily in M&A and new launches. Insider activity is dominated by routine, non-suggestive equity compensation transactions at Honeywell, with one notable sale at Walmart under a 10b5-1 plan. Capital allocation remains shareholder-friendly, with Caterpillar repurchasing $1.5B and paying $0.7B in dividends in Q2 2026, while Amgen paused buybacks. Key forward-looking catalysts include McDonald's leadership change to address U.S. underperformance, Merck's Terns acquisition integration, and Amgen's full-year repurchase cap. Overall, the theme is 'growth with caution'—strong operational performance in industrials contrasts with consumer softness and healthcare transition costs.